Patient Notification of Observation Status is Now Law
(By – Alexandra Wilson Pecci, for HealthLeaders Media) Under new federal law, Medicare patients who have been in the hospital for
Read More
Author: Gerry Hafer
African-Americans most likely to stop taking meds in Medicare Part D’s coverage gap
(By – Bert Gambini, www.buffalo.edu) Medicare Part D provides help to beneficiaries struggling with the cost of prescriptions drugs, but the
Read MoreMedicare proposal to limit amputees with prosthetics
(Source – www.wral.com) Medicare is making a proposal that would deny access to many people who need prosthetic limbs. The proposal, made
Read MoreLike A 1965 Ford Mustang, Medicare Needs a Redesign
(By – Howard Gleckman, Forbes Contributor) Medicare is the 1965 Ford Mustang of healthcare. It was cutting-edge back in the day.
Read MoreWaiving 3-day hospital requirement benefits patients, Medicare Advantage plans
(Source – www.healio.com) A recent study showed that waiving Medicare’s typical 3-day hospital stay requirement before becoming eligible for skilled nursing
Read MoreCMS Announces Timeline for Medicare DMEPOS Competitive Bidding
(Source – www.cms.gov) The Centers for Medicare & Medicaid Services (CMS) today announced the bidding timeline for the Round 1 2017
Read MoreTexas Whistleblower Says Medicare Advantage Plans Overstate Home Visit Charges
(Source – KHN Morning Briefing) A whistleblower case in Texas accuses a medical consulting firm and more than two dozen health
Read MoreOn Your Side Alert: Protecting your Medicare card from crooks
(By – Gray Hall, www.nbc12.com) If you’re nearing the age of 65, then you probably know you will soon be eligible for
Read MoreU.S. Deficit Grows in July on Higher Medicare, Veterans Payments
(By – Kasia Klimasinska, www.bloomberg.com) The U.S. budget deficit jumped 58 percent in July from a year earlier on higher spending,
Read MoreOnce Disparaged, ‘Me-Too’ Drugs Crucial For Lower Costs Of Cholesterol, Hepatitis C And Cancer Drugs
(By – John LaMattina, Forbes Contributor) While the high cost of new drugs is worrisome, those responsible for drug benefit plans
Read More